204 related articles for article (PubMed ID: 33509254)
1. Inflammation scores as prognostic biomarkers in small cell lung cancer: a systematic review and meta-analysis.
Winther-Larsen A; Aggerholm-Pedersen N; Sandfeld-Paulsen B
Syst Rev; 2021 Jan; 10(1):40. PubMed ID: 33509254
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as biomarkers to prognosticate survival in advanced gastric cancer patients in the era of immunotherapy: a systematic review and meta-analysis.
Matsas S; Aguiar PN; Del Giglio A
J Gastrointest Oncol; 2024 Feb; 15(1):33-51. PubMed ID: 38482212
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of systemic inflammatory markers in ovarian Cancer: a PRISMA-compliant meta-analysis and systematic review.
Zhu Y; Zhou S; Liu Y; Zhai L; Sun X
BMC Cancer; 2018 Apr; 18(1):443. PubMed ID: 29669528
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Pre-Treatment Neutrophil-To-Lymphocyte Ratio and Platelet-To-Lymphocyte Ratio in Patients With Brain Metastasis From Lung Cancer: A systematic Review and Meta-Analysis.
Li Z; Zhang W; Wu S
Altern Ther Health Med; 2023 Nov; ():. PubMed ID: 37944973
[TBL] [Abstract][Full Text] [Related]
5. Effect of systemic inflammation biomarkers on overall survival after lung cancer radiotherapy: a single-center large-cohort study.
Abravan A; Salem A; Price G; Faivre-Finn C; van Herk M
Acta Oncol; 2022 Feb; 61(2):163-171. PubMed ID: 34979860
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of blood inflammatory biomarkers NLR, PLR, and LMR in cancer-A protocol for systematic review and meta-analysis.
Kumarasamy C; Sabarimurugan S; Madurantakam RM; Lakhotiya K; Samiappan S; Baxi S; Nachimuthu R; Gothandam KM; Jayaraj R
Medicine (Baltimore); 2019 Jun; 98(24):e14834. PubMed ID: 31192906
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Pretreatment Lymphocyte-to-Monocyte Ratio in Lung Cancer: A Systematic Review and Meta-Analysis.
Jin J; Yang L; Liu D; Li WM
Technol Cancer Res Treat; 2021; 20():1533033820983085. PubMed ID: 33576324
[TBL] [Abstract][Full Text] [Related]
8. Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis.
Sacdalan DB; Lucero JA; Sacdalan DL
Onco Targets Ther; 2018; 11():955-965. PubMed ID: 29503570
[TBL] [Abstract][Full Text] [Related]
9. [Meta-analysis of Platelet Lymphocyte Ratio as A Prognostic Factor for
Non-small Cell Lung Cancer].
Chen H; Xue H; Liu W; Wu F; Wang Y; Gao H
Zhongguo Fei Ai Za Zhi; 2019 May; 22(5):289-298. PubMed ID: 31109438
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of the neutrophil-to-lymphocyte ratio in the prognosis and risk of death for adult sepsis patients: a meta-analysis.
Wu H; Cao T; Ji T; Luo Y; Huang J; Ma K
Front Immunol; 2024; 15():1336456. PubMed ID: 38562922
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of systemic inflammatory markers in esophageal cancer: Systematic review and meta-analysis.
Ishibashi Y; Tsujimoto H; Yaguchi Y; Kishi Y; Ueno H
Ann Gastroenterol Surg; 2020 Jan; 4(1):56-63. PubMed ID: 32021959
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with non-metastatic and metastatic prostate cancer: A meta-analysis and systematic review.
Salciccia S; Frisenda M; Bevilacqua G; Viscuso P; Casale P; De Berardinis E; Di Pierro GB; Cattarino S; Giorgino G; Rosati D; Del Giudice F; Sciarra A; Mariotti G; Gentilucci A
Asian J Urol; 2024 Apr; 11(2):191-207. PubMed ID: 38680577
[TBL] [Abstract][Full Text] [Related]
13. Preoperative systemic inflammatory markers as prognostic factors in differentiated thyroid cancer: a systematic review and meta-analysis.
Russo E; Guizzardi M; Canali L; Gaino F; Costantino A; Mazziotti G; Lania A; Uccella S; Di Tommaso L; Ferreli F; Malvezzi L; Spriano G; Mercante G
Rev Endocr Metab Disord; 2023 Dec; 24(6):1205-1216. PubMed ID: 37828383
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of absolute lymphocyte count and neutrophil-to-lymphocyte ratio for patients with metastatic breast cancer: a systematic review and meta-analysis.
Sang B; Fan Y; Wang X; Dong L; Gong Y; Zou W; Zhao G; He J
Front Oncol; 2024; 14():1360975. PubMed ID: 38515567
[TBL] [Abstract][Full Text] [Related]
15. Assessment of prognostic biomarkers in sudden sensorineural hearing loss: A systematic review and meta-analysis.
Niknazar S; Bazgir N; Shafaei V; Abbaszadeh HA; Zali A; Asghar Peyvandi A
Clin Biochem; 2023 Nov; 121-122():110684. PubMed ID: 37944628
[TBL] [Abstract][Full Text] [Related]
16. Systematic review and meta-analysis of the prognostic value of preoperative platelet-to-lymphocyte ratio in patients with urothelial carcinoma.
Wu S; Wan Q; Xu R; Zhu X; He H; Zhao X
Oncotarget; 2017 Oct; 8(53):91694-91702. PubMed ID: 29207678
[TBL] [Abstract][Full Text] [Related]
17. Use of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19.
Chan AS; Rout A
J Clin Med Res; 2020 Jul; 12(7):448-453. PubMed ID: 32655740
[TBL] [Abstract][Full Text] [Related]
18. Platelet-to-lymphocyte ratio could be a promising prognostic biomarker for survival of colorectal cancer: a systematic review and meta-analysis.
Peng HX; Lin K; He BS; Pan YQ; Ying HQ; Hu XX; Xu T; Wang SK
FEBS Open Bio; 2016 Jul; 6(7):742-50. PubMed ID: 27398314
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of inflammation-related biomarkers in patients with gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis.
Cui LJ; Yu FH; Cheng ZX; Su F; Chen YY; Tan HY
J Neuroendocrinol; 2024 Apr; 36(4):e13381. PubMed ID: 38468159
[TBL] [Abstract][Full Text] [Related]
20. Association of inflammatory biomarkers with overall survival in burn patients: a systematic review and meta-analysis.
Nourigheimasi S; Yazdani E; Ghaedi A; Khanzadeh M; Lucke-Wold B; Dioso E; Bazrgar A; Ebadi M; Khanzadeh S
BMC Emerg Med; 2024 Apr; 24(1):76. PubMed ID: 38684973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
